Novavax Inc (NVAX)

$7.93 -0.14 (-1.73%)
Market Cap 1.33B
Revenue (ttm) 1.12B
Net Income (ttm) 440.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 39.19%
Debt to Equity Ratio -1.53
Volume 2,014,900
Avg Vol 3,684,422
Day's Range N/A - N/A
Shares Out 164.95M
Stochastic %K 57%
Beta 2.47
Analysts Sell
Price Target $13.45

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
21 Firstfield Road, Gaithersburg, United States
BensonFuller
BensonFuller Aug. 19 at 12:34 PM
$NVAX If Novavax had a CEO like Moderna's the share price would be closer to 40 with an approved Flu vaccine and a Phase 3 Pivotal CIC trial already completed. Instead, we have that fucking loser John "Happy Talk/Penny Stock/Do Nothing" Jacobs
0 · Reply
BTC321
BTC321 Aug. 19 at 12:31 PM
$NVAX good results for oncology at $MRNA NOVAVAX next! Biotech needs a good oncology aduvant!!!
0 · Reply
kwinters71
kwinters71 Aug. 19 at 12:26 PM
$NVAX what’s going on?
1 · Reply
Pissed_of_retards2
Pissed_of_retards2 Aug. 19 at 12:25 PM
$NVAX now imagine if we posted phase 3a data and it did a 1% pop.. but we will wait for this maybe bit more
0 · Reply
ddirk
ddirk Aug. 19 at 12:22 PM
$NVAX they go after #fJJ just talked about doing something in oncology
0 · Reply
ddirk
ddirk Aug. 19 at 12:20 PM
$NVAX well said NR , we have worthless CEO
0 · Reply
Stan_The_Man_Erck
Stan_The_Man_Erck Aug. 19 at 12:18 PM
$NVAX Meanwhile while Moderna goes after real issues like oncology, NVAX pumpers are still giddy about a nonexistent NVAX Covid/Flu combo vaccine that nobody will take.
0 · Reply
BTC321
BTC321 Aug. 19 at 12:17 PM
$NVAX Trending again NOVAFAM!
0 · Reply
ddirk
ddirk Aug. 19 at 12:17 PM
$NVAX sale price going down as JJ can’t capitalize on the fact that mRNA is doing well
0 · Reply
BTC321
BTC321 Aug. 19 at 12:15 PM
$NVAX WE GONNA HAVE THE NEXT GREAT MATRIX-M ADJUVANT CANCER NEWS! LET'S GOOOOOOOOO
0 · Reply
Latest News on NVAX
Novavax Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 13 days ago

Novavax Earnings Call Transcript: Q2 2026

Novavax Quarterly report: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 13 days ago

Novavax Quarterly report: Q2 2026

Novavax Earnings release: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 13 days ago

Novavax Earnings release: Q2 2026

Novavax Slides: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 13 days ago

Novavax Slides: Q2 2026

Novavax reports Q2 EPS (32c), consensus (38c)

2026-08-06T12:22:31.000Z - 13 days ago

Novavax reports Q2 EPS (32c), consensus (38c)

Novavax raises 2026 adjusted revenue view to $235M-$275M from $230M-$270M

2026-08-06T12:21:31.000Z - 13 days ago

Novavax raises 2026 adjusted revenue view to $235M-$275M from $230M-$270M

Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand

Aug 6, 2026, 8:04 AM EDT - 13 days ago

Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Jul 30, 2026, 7:00 AM EDT - 20 days ago

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Novavax put volume heavy and directionally bearish

2026-07-10T15:15:11.000Z - 5 weeks ago

Novavax put volume heavy and directionally bearish

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

Jun 24, 2026, 8:00 AM EDT - 2 months ago

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

Novavax put volume heavy and directionally bearish

2026-06-22T15:15:08.000Z - 2 months ago

Novavax put volume heavy and directionally bearish

Novavax Transcript: AGM 2026

Jun 18, 2026, 8:30 AM EDT - 2 months ago

Novavax Transcript: AGM 2026

Novavax Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 10:30 AM EDT - 2 months ago

Novavax Transcript: Jefferies Global Healthcare Conference 2026

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Jun 1, 2026, 4:00 PM EDT - 2 months ago

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Novavax Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 6:40 PM EDT - 3 months ago

Novavax Transcript: Bank of America Global Healthcare Conference 2026

Novavax Slides: Corporate presentation

May 12, 2026, 7:00 AM EDT - 3 months ago

Novavax Slides: Corporate presentation

Hantavirus cases spark surge in pharma and biotech stocks — here's why

May 11, 2026, 7:53 AM EDT - 3 months ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO MRNA

Novavax to Participate in BofA Securities 2026 Health Care Conference

May 7, 2026, 4:00 PM EDT - 3 months ago

Novavax to Participate in BofA Securities 2026 Health Care Conference

Novavax Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Earnings Call Transcript: Q1 2026

Novavax Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Quarterly report: Q1 2026

Novavax Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Earnings release: Q1 2026

Novavax Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Slides: Q1 2026

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

May 6, 2026, 8:00 AM EDT - 3 months ago

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

Novavax beats first-quarter revenue estimates on vaccine deals strength

May 6, 2026, 7:56 AM EDT - 3 months ago

Novavax beats first-quarter revenue estimates on vaccine deals strength

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 29, 2026, 4:00 PM EDT - 3 months ago

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Novavax Proxy statement: Proxy filing

Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Novavax Proxy statement: Proxy filing

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Apr 8, 2026, 6:08 AM EDT - 4 months ago

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:40 PM EDT - 5 months ago

Novavax Transcript: Leerink Global Healthcare Conference 2026

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 2:30 PM EST - 6 months ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 4:30 PM EST - 6 months ago

Novavax to Participate in Upcoming Investor Conferences

Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Earnings Call Transcript: Q4 2025

Novavax Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Earnings release: Q4 2025

Novavax Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Annual report: Q4 2025

Novavax Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Slides: Q4 2025

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Feb 26, 2026, 8:06 AM EST - 6 months ago

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Feb 26, 2026, 8:00 AM EST - 6 months ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Feb 19, 2026, 8:00 AM EST - 6 months ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:15 AM EST - 7 months ago

Novavax Announces Entering into a License Agreement with Pfizer

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 7 months ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 7 months ago

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 7 months ago

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 7 months ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 9 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 9 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

Dec 1, 2025, 9:59 AM EST - 9 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 11:30 AM EST - 9 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 4:41 PM EST - 9 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Novavax to Participate in Jefferies London Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 9 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Earnings Call Transcript: Q3 2025

Novavax Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Earnings release: Q3 2025

Novavax Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Quarterly report: Q3 2025

Novavax Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Slides: Q3 2025

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 8:00 AM EST - 10 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 6, 2025, 7:58 AM EST - 10 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Nov 4, 2025, 7:00 AM EST - 10 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 30, 2025, 8:00 AM EDT - 10 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 22, 2025, 7:00 AM EDT - 10 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 14, 2025, 6:09 AM EDT - 11 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Oct 7, 2025, 7:00 AM EDT - 11 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax Announces Progress on Sanofi Agreement

Sep 30, 2025, 9:01 AM EDT - 11 months ago

Novavax Announces Progress on Sanofi Agreement

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 11 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 10:20 AM EDT - 1 year ago

Novavax Transcript: Cantor Global Healthcare Conference 2025

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Novavax to Participate in the Cantor Global Healthcare Conference

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Novavax to Participate in the Cantor Global Healthcare Conference

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 27, 2025, 3:07 PM EDT - 1 year ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Novavax Announces Convertible Debt Refinancing

Aug 21, 2025, 7:43 AM EDT - 1 year ago

Novavax Announces Convertible Debt Refinancing

Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings Call Transcript: Q2 2025

Novavax Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings release: Q2 2025

Novavax Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Quarterly report: Q2 2025

Novavax Slides: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Slides: Q2 2025

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:08 AM EDT - 1 year ago

Novavax beats quarterly revenue estimates on milestone payment

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Novavax Slides: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Slides: Goldman Sachs 46th Annual Global Healthcare Conference

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:11 AM EDT - 1 year ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 1 year ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 1 year ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 20, 2025, 4:34 PM EDT - 1 year ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 9:27 AM EDT - 1 year ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:16 AM EDT - 1 year ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

BensonFuller
BensonFuller Aug. 19 at 12:34 PM
$NVAX If Novavax had a CEO like Moderna's the share price would be closer to 40 with an approved Flu vaccine and a Phase 3 Pivotal CIC trial already completed. Instead, we have that fucking loser John "Happy Talk/Penny Stock/Do Nothing" Jacobs
0 · Reply
BTC321
BTC321 Aug. 19 at 12:31 PM
$NVAX good results for oncology at $MRNA NOVAVAX next! Biotech needs a good oncology aduvant!!!
0 · Reply
kwinters71
kwinters71 Aug. 19 at 12:26 PM
$NVAX what’s going on?
1 · Reply
Pissed_of_retards2
Pissed_of_retards2 Aug. 19 at 12:25 PM
$NVAX now imagine if we posted phase 3a data and it did a 1% pop.. but we will wait for this maybe bit more
0 · Reply
ddirk
ddirk Aug. 19 at 12:22 PM
$NVAX they go after #fJJ just talked about doing something in oncology
0 · Reply
ddirk
ddirk Aug. 19 at 12:20 PM
$NVAX well said NR , we have worthless CEO
0 · Reply
Stan_The_Man_Erck
Stan_The_Man_Erck Aug. 19 at 12:18 PM
$NVAX Meanwhile while Moderna goes after real issues like oncology, NVAX pumpers are still giddy about a nonexistent NVAX Covid/Flu combo vaccine that nobody will take.
0 · Reply
BTC321
BTC321 Aug. 19 at 12:17 PM
$NVAX Trending again NOVAFAM!
0 · Reply
ddirk
ddirk Aug. 19 at 12:17 PM
$NVAX sale price going down as JJ can’t capitalize on the fact that mRNA is doing well
0 · Reply
BTC321
BTC321 Aug. 19 at 12:15 PM
$NVAX WE GONNA HAVE THE NEXT GREAT MATRIX-M ADJUVANT CANCER NEWS! LET'S GOOOOOOOOO
0 · Reply
GeeKar
GeeKar Aug. 19 at 12:14 PM
$NVAX The immortal quote by Nora Roberts that perfectly mirrors a driven, proactive corporate leader versus 'in name only leader' like John C. Jacobs
0 · Reply
Trader00995
Trader00995 Aug. 19 at 12:13 PM
$NVAX hahahahaa jacobs you f idiot🤣 While you signing fake MTA's , look what real ceo doing😉🤡
0 · Reply
Benroxx
Benroxx Aug. 19 at 12:10 PM
$NVAX Scumbag JJ
0 · Reply
DifferentRadar
DifferentRadar Aug. 19 at 12:10 PM
$NVAX While I wish this was our news, it's still a huge validation of the oncology market and our potential value, too. I'm actually surprised $NVAX hasn't moved up higher in sympathy.
1 · Reply
GenZinvestor561
GenZinvestor561 Aug. 19 at 12:09 PM
$NVAX we’ll be red by 12
1 · Reply
Pissed_of_retards2
Pissed_of_retards2 Aug. 19 at 12:07 PM
$NVAX 1 positive outcome of mrna success is that now they can potentially afford acquire novavax for 3-4 billions
0 · Reply
Benroxx
Benroxx Aug. 19 at 12:06 PM
$NVAX I cant belive this #fjj
0 · Reply
Benroxx
Benroxx Aug. 19 at 12:06 PM
$NVAX Its a small drag mRNA pluss 102% we only 6 very bad very very bad, #fjj
0 · Reply
Stan_The_Man_Erck
Stan_The_Man_Erck Aug. 19 at 12:01 PM
$NVAX Remember when the Pumpers said MRNA vaccines were going away https://finance.yahoo.com/markets/stocks/articles/moderna-shares-soar-60-on-melanoma-vaccine-trial-success-113706098.html
0 · Reply
dkallday
dkallday Aug. 19 at 12:01 PM
$NVAX So moderna ceo buying shares a week before this news is not suspicious
2 · Reply
ddirk
ddirk Aug. 19 at 12:00 PM
$MRNA $NVAX that would require doing work from #fJJ and management
0 · Reply
SelfMafia
SelfMafia Aug. 19 at 12:00 PM
$NVAX NEVERVAX is a garbage stock with garbage mgmt Nothing like $MRNA or other bios that execute Scam since day 1
2 · Reply